Model
Edge
Dicerna Pharmaceuticals Inc
0001399529
Filing Type
8-K
Filing Date
12/27/2021
Updated
12/28/21, 2:28 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-3.1
EX-3.1
EX-3.2
EX-3.2
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events